Category:

Johnson & Johnson has been hit with billions in talc verdicts, but it's had mixed success in appeals. With a new decision...the company chalked up its latest appeals win...A court in J&J's home state of New Jersey struck down a $117 million verdict against the drugmaker originally handed down there in 2018...The court ruled that the trial judge shouldn’t have allowed certain expert testimony, so J&J and its talc partner Imerys—which has since declared bankruptcy—deserve another trial...READ MORE

The European Commission said on Monday it had launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries...Under the contract, the Anglo-Swedish company had committed to making its "best reasonable efforts" to deliver 180 million vaccine doses to the EU in the second quarter of this year, for a total of 300 million in the period from December to June...But AstraZeneca said in a statement on March 12 it would aim to deliver only one-third of that by the end of June, of which about 70 million would be in the second quarter. A week after that, the Commission sent a legal letter to the company in the first step of a formal procedure to resolve disputes...Read More

Johnson & Johnson said Friday that it has negotiated a warning label for its Covid-19 vaccine to make health care providers aware of a potentially increased risk of rare but severe blood clots and low platelet counts...The vaccine maker revealed the warning text, which it said the Food and Drug Administration had agreed to, during a presentation Friday before a Centers for Disease Control and Prevention vaccine advisory panel...Neither the FDA nor CDC has said they will adopt a warning label...READ MORE

• Electronic Prescribing Mandate for Controlled Substances
• National Pharmacy Compliance News
• Guidelines, Materials Available to Health Care Providers for Safely Administering COVID-19 Vaccines
• FDA Issues Guidance to Protect Consumers From Methanol Poisoning
• Standardize Concentrations for Oral Liquid Preparations
• Opioid Use Disorder Educational Programs, Resources Available for Pharmacists
• National Diabetes Prevention Program – How Pharmacists Can Get Involved
• Surgery Patients Receive More Opioids in the US Than in Other Countries
• Study Finds 94% Drop in Symptomatic COVID-19 Cases With Pfizer’s Vaccine
• NABP Executive Director/Secretary Addresses Pharmacists’ Involvement in COVID-19 Vaccination During FIP Webinar

In 2020, Indivior resolved the federal government's long-running probe into its aggressive marketing of the opioid addiction therapy Suboxone, reaching a $600 million plea deal. Now, it's paying up...Indivior will shell out $300 million to all 50 states, the District of Columbia and Puerto Rico to resolve claims that it “falsely and aggressively” marketed its opioid addiction drug Suboxone, leading to misuse of state Medicaid funds, California Attorney General Rob Bonta...READ MORE

The United States will resume Johnson & Johnson COVID-19 vaccinations after health officials lifted an 11-day pause on the shots at the recommendation of a Centers for Disease Control and Prevention advisory panel...The panel voted 10 to 4 to recommend restarting the vaccinations, saying the benefits of the shot outweigh the rare risk of blood clots. However, the group suggested that the vaccine include a warning about the increased risk of the very rare but severe blood clots...READ MORE

Two U.S. representatives, G.K. Butterfield and David McKinley introduced the Pharmacy and Medically Underserved Area Enhancement Act, which would provide reimbursement to pharmacists who deliver Medicare Part B services that are already authorized by their respective state laws...“Under this bill, Medicare will pay pharmacists at 85% of the Physician Fee Schedule,” explained Tom Kraus, the vice president of government relations at ASHP. “This is an important step to improve access to care for Medicare beneficiaries and helps ensure that serving these patients will be financially sustainable.”...READ MORE

The United States is sending supplies worth more than $100 million to India to help it fight a surge of COVID-19 cases...The supplies...include 1,000 oxygen cylinders, 15 million N95 masks and 1 million rapid diagnostic tests...The United States also has redirected its own order of AstraZeneca manufacturing supplies to India, which will allow it to make over 20 million doses of COVID-19 vaccine...READ MORE

A Las Vegas man has pleaded guilty to bilking North Carolina Medicaid out of $13 million, prompting the forfeiture of an airplane, a sports car, a pickup, land and luxury jewelry...Timothy Harron, 52, has pleaded guilty to conspiracy to commit health care fraud, wire fraud, money laundering, and aggravated identity theft. Authorities said the guilty plea requires him to forfeit cash and luxury items...READ MORE

Johnson & Johnson’s takeover of COVID-19 vaccine manufacturing at an error-prone Emergent BioSolutions plant in Baltimore didn’t last long...Two weeks after the U.S. stepped in and handed control of vaccine manufacturing at the plant to J&J, Emergent agreed to temporarily halt producing new drug substance there...READ MORE